On March 5, 2020, the U.S. Environmental Protection Agency (EPA) announced that it is seeking grant applications through the Source Reduction Assistance Grant Program from states, federally recognized tribes, universities, local governments, and other groups to support innovative solutions for source reduction or pollution prevention (P2) through research, education, training, or certain other methods. EPA notes that as it highlights chemical safety during the month of March, “these...
Archives
October 31, 2014
President Obama Announces $300 Million Investment In Emerging Manufacturing Technologie
On October 27, 2014, President Obama announced new plans to strengthen the manufacturing sector. One of the listed plans involved the Departments of Defense, Energy, and Agriculture, and the National Aeronautics and Space Administration (NASA) coming together to invest in advanced materials, advanced sensors, and digital manufacturing. These three areas were determined to be critical to U.S. competitiveness and include biobased materials in the advanced materials category. Over $300 million is...
September 26, 2014
The Revitalize American Manufacturing And Innovation Act Passes House Of Representative
On September 15, 2014, the U.S. House of Representatives passed H.R. 2996, the Revitalize American Manufacturing and Innovation (RAMI) Act. The Act "earmarks up to $300 million in federal funding — $30 million annually for 10 years" from the U.S. Department of Energy's Energy Efficiency and Renewable Energy account, and would be available to regional centers to develop new products and train workforces. Fields mentioned in the bill as eligible for the money include...
July 7, 2014
Valent BioSciences Marks New Iowa Facility
On June 27, 2014, Valent BioSciences (Valent) Corporation announced that it held a ceremony to mark the opening of its new $146 million biobased manufacturing facility in Osage, Iowa. A copy of Valent's press release is available online....
On June 3, 2010, the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Office of Pharmaceutical Science (OPS) posted on its website a Manual of Policies and Procedures (MAPP) entitled “Reporting Format for Nanotechnology-Related Information in CMC Review.” The purpose of the MAPP is to provide chemistry, manufacturing, and controls (CMC) reviewers within OPS with the framework by which relevant information about nanomaterial-containing drugs will now be...